Key facts
- This page summarizes Anthony N. Amato's Form 4 filing for BioSig Technologies, Inc. (BSGM).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Jun 2025, 17:30.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
The shares of common stock were granted under the Company's 2023 Equity Incentive Plan in lieu of cash for services and were fully vested as of May 29, 2025 (the "Date of Grant"), based on a closing price of $5.05 per share on such date.